Second Generation Antipsychotics and Risk of Diabetes Type II – Comparison between
Olanzapine and Risperidone Page 1 Coll. Antropol. 31 (2007) 4: 1105–1109 Original scientific …

Background. Some atypical antipsychotics have been linked to hyperglycemia, diabetes
mellitus, and diabetic ketoacidosis. We reviewed evidence comparing excess risk and …

Background: Case series suggest that some antipsychotics may induce or exacerbate type 2
diabetes. This study measured the association of antipsychotic treatments with diabetes at a …

Atypical antipsychotic (AAP) agents are useful in treating patients with schizo-phrenia and
other psychosis. Their advantages are the low incidence of extrapyramidal side effects, and …

Background: Atypical antipsychotics are being used increasingly in the management of
mood disorders. Objective: The objective of this study was to investigate the association …

Background: Case series suggest that some antipsychotics may induce or exacerbate type 2
diabetes. This study measured the association of antipsychotic treatments with diabetes at a …

1. Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in
dementia trials. CMAJ 2002; 167 (11): 1269-70. 2. McIntyre RS, McCann SM, Kennedy SH …

Objectives. A growing body of literature suggests that certain atypical antipsychotics,
especially olanzapine and clozapine, may induce glucoregulatory dysfunction. We assessed …

Purpose The purpose of this study was to examine the association between atypical
antipsychotics, including the newer agents, aripiprazole and ziprasidone, and newly treated …

BackgroundTreatment with antipsychotics seems to increase the risk of developing diabetes
but the association is poorly characterised in clinical practice. AimsTo investigate and …